Nutritional High Announces Changes to Board of Directors
Feb 20, 2018 13:18 pm UTC| Business
TORONTO, Feb. 20, 2018 -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to announce the appointment of Jim Frazier and Aaron Johnson as...
Global Spear Phishing Protection Market rising to a valuation of US$1,839.8 mn by 2025 | TMR
Feb 20, 2018 13:17 pm UTC| Business
ALBANY, New York, Feb. 20, 2018 -- In the highly competitive vendor landscape for the global spear phishing protection market, companies are focusing on the development of technologically advanced and innovative spear...
General Cannabis Announces Record 2017 Fourth Quarter Revenues and Elimination of Debt
Feb 20, 2018 13:15 pm UTC| Business
DENVER, Feb. 20, 2018 -- General Cannabis Corp (OTCQB:CANN), the comprehensive national resource to the regulated cannabis industry, today announced revenue results for the quarter ended December 31, 2017. Revenue...
Feb 20, 2018 13:15 pm UTC| Business
NEW YORK, Feb. 20, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spire Inc....
Gladstone Commercial Corporation Announces Sale of Arlington, TX Property for $5.6 million
Feb 20, 2018 13:15 pm UTC| Business
MCLEAN, Va., Feb. 20, 2018 -- Gladstone Commercial Corporation (NASDAQ:GOOD) announced today that it sold its 64,000 square foot industrial property located in Arlington, Texas for gross proceeds of $5.6 million. The...
Wabtec Reports Results For 2017 4Q and Full Year, Issues 2018 Financial Guidance
Feb 20, 2018 13:14 pm UTC| Business
WILMERDING, Pa., Feb. 20, 2018 -- Wabtec Corporation (NYSE:WAB) today reported results for the 2017 fourth quarter and full year, and issued 2018 financial guidance. 2017 SummaryIn the fourth quarter of...
Feb 20, 2018 13:11 pm UTC| Business
BUFFALO, N.Y., Feb. 20, 2018 -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...